Grant: Collaborative Health Research Projects
University of Toronto
$79,500.00
High-throughput sperm motility assay and automated selection for clinical in vitro fertilization
EF 2013-14
Résumé
This proposal describes the development and application of a high-throughput sperm physiological motilitymeasurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate thetendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screencandidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterativesegments of device development, initial testing, and human sperm based testing, followed by implementation atthe OVO Fertility Clinic.In Canada, one in six couples experience fertility issues and each year an estimated 3500 live birthsinvolve assisted reproductive technologies, most notably IVF. Current techniques of semen processing andsperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques maybe ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, includingthe sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk ofpregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for aclinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNAdamage while reflecting as much as possible the natural in vivo process.This project is a new collaboration enabled through the CHRP opportunity. The project brings togetherengineering and male and female fertility health researchers, and IVF treatment providers at the OVO FertilityClinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human spermmotility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of thesefindings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercializationopportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills neededto develop next-generation fertility treatments.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
399337-2011
Name nom
Sinton, David
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
79500
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
3
Nb partie
3
Application title
High-throughput sperm motility assay and automated selection for clinical in vitro fertilization
Keyword
NSERC
Application summary
This proposal describes the development and application of a high-throughput sperm physiological motilitymeasurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate thetendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screencandidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterativesegments of device development, initial testing, and human sperm based testing, followed by implementation atthe OVO Fertility Clinic.In Canada, one in six couples experience fertility issues and each year an estimated 3500 live birthsinvolve assisted reproductive technologies, most notably IVF. Current techniques of semen processing andsperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques maybe ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, includingthe sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk ofpregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for aclinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNAdamage while reflecting as much as possible the natural in vivo process.This project is a new collaboration enabled through the CHRP opportunity. The project brings togetherengineering and male and female fertility health researchers, and IVF treatment providers at the OVO FertilityClinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human spermmotility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of thesefindings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercializationopportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills neededto develop next-generation fertility treatments.